FBLG · ISSUER CIK 1958777
FibroBiologics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 FibroBiologics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202619:26 | Sep 15, 2026 | FBLG | Chief Scientific Officer | A · Grant | $1.68 | +298,508 | 301,571 | +9746% | $500K |